Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
Do you have a preference between midodrine and droxidopa for patients with ESKD who experience intradialytic hypotension?
Related Questions
How do you counsel patients on peritoneal dialysis regarding the safety of engaging in aerobic and resistance exercises, considering the risk of developing abdominal wall complications?
What is your blood pressure threshold to hold an ESA for patients with ESKD, anemia, and hypertension?
Would you opt to start IV iron load, maintenance iron therapy, or no iron at all in a patient with ESKD on hemodialysis who has a stable hemoglobin level at around 12.0 g/dL but also has low iron stores as evidenced by a low transferrin saturation and ferritin?
Would you consider reducing the dialysate sodium concentration to 135 meq/L as a strategy to decrease interdialytic weight gain in a hypervolemic ESKD patient?
What is your PTH target for patients with ESKD and brown tumor?
How do you work up and manage an ESKD patient with controlled blood pressure who complains of recurrent headaches while on hemodialysis?
Would you refer an ESKD patient with an identified living donor for AV access placement if kidney transplantation is anticipated in 4 months?
Do you avoid sodium zirconium cyclosilicate use in your patients with ESKD and hyperkalemia who also have peripheral edema?
What are your top takeaways from ASN 2024?
What is your preferred method for latent tuberculosis screening prior to outpatient hemodialysis initiation for a patient with new dialysis requirements?
